4.7 Article

COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters

Journal

GENOMICS PROTEOMICS & BIOINFORMATICS
Volume 19, Issue 5, Pages 669-678

Publisher

ELSEVIER
DOI: 10.1016/j.gpb.2021.09.006

Keywords

SARS-CoV-2; Protein microarray; Humoral immunity; One-stop tool; Shiny

Funding

  1. National Key R&D Program of China [2016YFA0500600]
  2. National Natural Science Foundation of China [31970130, 31600672, 31900112, 21907065, 32000027]

Ask authors/readers for more resources

The database COVID-ONE-hi provides an analysis of COVID-19-specific IgG/IgM immune responses and clinical parameters, based on data from 783 COVID-19 patients. It offers a comprehensive analysis report for further interpretation and is freely available for use at www.COVID-ONE.cn.
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (named COVID-ONE-hi). COVID-ONE-hi is based on the data that contain the IgG/IgM responses to 24 full-length/truncated proteins corresponding to 20 of 28 known SARS-CoV-2 proteins and 199 spike protein peptides against 2360 serum samples collected from 783 COVID-19 patients. In addition, 96 clinical parameters for the 2360 serum samples and basic information for the 783 patients are integrated into the database. Furthermore, COVID-ONE-hi provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the START button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-hi is freely available at www.COVID-ONE.cn.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available